De novo malignancy after living donor liver transplantation: a large volume experience
ConclusionThe incidence of de novo malignancy was 1% at a median follow up of 42 (32-73) months. De novo malignancies following LDLT, although uncommon, are associated with significant mortality. A careful screening protocol should be followed post transplantation for early detection of de novo malignancies.
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research
More News: Alcoholism | Brain | Cancer & Oncology | Carcinoma | Databases & Libraries | Gastric (Stomach) Cancer | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Transplant | Lung Transplant | Lymphoma | Neurology | Oral Cancer | Oropharyngeal Cancer | Ovaries | Pancreas | Pancreatic Cancer | Skin | Skin Cancer | Squamous Cell Carcinoma | Transplant Surgery | Transplants | Urology & Nephrology